Vsevolod Andreevich Skribitsky

Mr. Vsevolod Andreevich Skribitsky

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ALAlexey Andreevich Lipengolts
Alexey Andreevich Lipengolts
YFYulia Andreevna Finogenova
Yulia Andreevna Finogenova
VSVsevolod Andreevich Skribitsky
Vsevolod Andreevich Skribitsky
KSKristina E. Shpakova
Kristina E. Shpakova
AAAdi Anaki
Adi Anaki
RPRachela Popovtzer
Rachela Popovtzer
Gold-containing nanoparticles are proven to be an effective radiosensitizer in the radiotherapy of tumors. Reliable imaging of nanoparticles in a tumor and surrounding normal tissues is crucial both for diagnostics and for nanoparticle application as radiosensitizers. The Fe3O4 core was introduced into gold nanoparticles to form a core/shell structure suitable for MRI imaging. The aim of this study was to assess the in vivo bimodal CT and MRI enhancement ability of novel core/shell Fe3O4@Au theranostic nanoparticles. Core/shell Fe3O4@Au nanoparticles were synthesized and coated with PEG and glucose. C57Bl/6 mice bearing Ca755 mammary adenocarcinoma tumors received intravenous injections of the nanoparticles. CT and MRI were performed at several timepoints between 5 and 102 min, and on day 17 post-injection. Core/shell Fe3O4@Au nanoparticles provided significant enhancement of the tumor and tumor blood vessels. Nanoparticles also accumulated in the liver and spleen and were retained in these organs for 17 days. Mice did not show any signs of toxicity over the study duration. These results indicate that theranostic bimodal Fe3O4@Au nanoparticles are non-toxic and serve as effective contrast agents both for CT and MRI diagnostics. These nanoparticles have potential for future biomedical applications in cancer diagnostics and beyond.

Verified
Journal Article
Open access
PDF file
Natalia PozdniakovaNatalia Pozdniakova
Natalia Pozdniakova
OROxana Ryabaya
Oxana Ryabaya
ASAlevtina Semkina
Alevtina Semkina
VSVsevolod Andreevich Skribitsky
Vsevolod Andreevich Skribitsky
ASAlexei B. Shevelev
Alexei B. Shevelev
Three artificial proteins that bind the gadolinium ion (Gd3+) with tumour-specific ligands were de novo engineered and tested as candidate drugs for binary radiotherapy (BRT) and contrast agents for magnetic resonance imaging (MRI). Gd3+-binding modules were derived from calmodulin. They were joined with elastin-like polypeptide (ELP) repeats from human elastin to form the four-centre Gd3+-binding domain (4MBS-domain) that further was combined with F3 peptide (a ligand of nucleolin, a tumour marker) to form the F3-W4 block. The F3-W4 block was taken alone (E2-13W4 protein), as two repeats (E1-W8) and as three repeats (E1-W12). Each protein was supplemented with three copies of the RGD motif (a ligand of integrin αvβ3) and green fluorescent protein (GFP). In contrast to Magnevist (a Gd-containing contrast agent), the proteins exhibited three to four times higher accumulation in U87MG glioma and A375 melanoma cell lines than in normal fibroblasts. The proteins remained for >24 h in tumours induced by Ca755 adenocarcinoma in C57BL/6 mice. They exhibited stability towards blood proteases and only accumulated in the liver and kidney. The technological advantages of using the engineered proteins as a basis for developing efficient and non-toxic agents for early diagnosis of tumours by MRI as well as part of BRT were demonstrated.

1 December 2022 in Physics of Atomic Nuclei
Verified
Journal Article
Closed access
PDF file
VSVsevolod Andreevich Skribitsky
Vsevolod Andreevich Skribitsky
YFYu. A. Finogenova
Yu. A. Finogenova
ALA. A. Lipengolts
A. A. Lipengolts
NPN. V. Pozdniakova
N. V. Pozdniakova
ASA. V. Smirnova
A. V. Smirnova
EGE. Yu. Grigorieva
E. Yu. Grigorieva
Gold nanoparticles (GNPs) are actively used as dose enhancing agents in combination with X-ray irradiation. The synthesis of gold nanoparticles by laser ablation has a number of advantages over other methods (for example, the possibility of preparing a chemically pure solution and a relatively low production cost when synthesis is scaled up). An additional antitumor effect from the combined use of gold nanoparticles synthesized by laser ablation and X-rays was studied. Mice transplanted subcutaneously with Ca755 syngeneic adenocarcinoma were used for the study. The tumor was irradiated at a dose of 10 Gy in 30 min after injection of GNPs. As a result, 66% of complete regressions were found in the experimental group of mice within 210 days after transplantation, while there were no regressions of tumor nodes in the control irradiated group. The absorbed dose to the vascular walls with gold nanoparticles in the bloodstream was evaluated as 26.8 Gy owing to local energy release.

1 February 2022 in Biophysics
Verified
Journal Article
Closed access
PDF file
VSVsevolod Andreevich Skribitsky
Vsevolod Andreevich Skribitsky
NPN. V. Pozdniakova
N. V. Pozdniakova
ALA. A. Lipengolts
A. A. Lipengolts
APA. A. Popov
A. A. Popov
GTG. V. Tikhonowski
G. V. Tikhonowski
EGE. Yu. Grigorieva
E. Yu. Grigorieva
—The ability to use a spectrophotometric method to estimate the size and concentration of gold nanoparticles obtained by the method of laser ablation was considered. Gold nanoparticles synthesized by different methods have different physical and chemical properties of their surface. This can affect their optical properties in a colloidal solution. The results obtained in this work confirm the ability to use the spectrophotometric method to estimate the size and concentration of nanoparticles obtained by the method of laser ablation. It was demonstrated that it is optimal to estimate the concentration of nanoparticles using the spectrophotometric method at a wavelength of 400 nm. The determination of the size of nanoparticles by the absorption spectra in the ultraviolet and visible regions is possible for particles with a size of at least 11 nm.

Verified
Journal Article
Open access
PDF file
MRMargarita Ryabchikova
Margarita Ryabchikova
ANAleksey Nelyubin
Aleksey Nelyubin
Ilya KlyukinIlya Klyukin
Ilya Klyukin
NSNikita Alekseevich Selivanov
Nikita Alekseevich Selivanov
ABAlexander Yu. Bykov
Alexander Yu. Bykov
NKNikolay T. Kuznetsov
Nikolay T. Kuznetsov
In this work, a series of boronated amidines based on the closo-dodecaborate anion and amino acids containing an amino group in the side chain of the general formula [B12H11NHC(NH(CH2)nCH(NH3)COOH)CH3], where n = 2, 3, 4, were synthesized. These derivatives contain conserved α-amino and α-carboxyl groups recognized by the binding centers of the large neutral amino acid transporter (LAT) system, which serves as a target for the clinically applied BNCT agent para-boronophenylalanine (BPA). The paper describes several approaches to synthesizing the target compounds, their acute toxicity studies, and tumor uptake studies in vivo in two tumor models. The promising compound [B12H11NHC(NH(CH2)2CH(NH3)COOH)CH3]*3H2O demonstrates low toxicity (LD50 in a range from 150 to 300 mg/kg) and excellent solubility and also shows selective uptake in experimental melanoma in laboratory mice (T/N ratio remained >3 up to 60 min post-injection, with a maximum T/N of 6.2 ± 2.8 at 45 min).

26 December 2024 in Journal of oncology: diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
YFYulia Andreevna Finogenova
Yulia Andreevna Finogenova
ALAlexey Andreevich Lipengolts
Alexey Andreevich Lipengolts
KSKristina E. Shpakova
Kristina E. Shpakova
VSVsevolod Andreevich Skribitsky
Vsevolod Andreevich Skribitsky
ASAnna V. Вячеславна Smirnova
Anna V. Вячеславна Smirnova
EGElena Grigorieva
Elena Grigorieva
Neutron Capture Therapy (NCT) — highly selective method of binary radiotherapy of malignancies, which is based on physical phenomenon of thermal neutron radiation capture by atoms’ nuclei. Currently only 10B mediated NCT, known as boron neutron capture therapy (BNCT), is used in clinical practice. Boronophenylalanine — a modified amino acid is most widely used as 10B carrier. Despite of more than 70-years history of BCNT clinical application and promising results of curing patients with different tumors, this method of treatment is still under research and development. The most urgent issue is studying and prediction of radiation effects of healthy and tumor tissues after BNCT application. This task can be solved in experiments involving animals. The review contains results of BNCT studies both in laboratory animals with different tumor models and veterinary practice. Induced and transplanted models of central nervous system, oral cavity as well as subcutaneous and metastatic models are considered in the review. Obtained results of the studies show possible high antitumor efficacy of BPA mediated BNCT and fundamentally different mechanisms of BNCT effect on tumor and healthy tissues comparing to other known types of radiotherapy. Many issues still require addition research with modern methods of studies, such as in vivo preclinical imaging.